Boston Tech
Endpoint Buys Boston’s Bluefin to Keep Clinical Trials Out of Spreadsheet Purgatory
Endpoint Clinical acquired Boston-based Bluefin to connect trial supply forecasts with live execution data, while promising customers continued vendor choice.